Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
200 participants
OBSERVATIONAL
2023-12-01
2024-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
cohort of cervical cancer organoids
organoids derived from cervical cancer
construction of organoids from gynecological tumor
organoids construction
cohort of endometrial cancer organoids
organoids derived from endometrial cancer
construction of organoids from gynecological tumor
organoids construction
cohort of ovarian cancer organoids
organoids derived from ovarian cancer
construction of organoids from gynecological tumor
organoids construction
cohort of vulva cancer organoids
organoids derived from vulva cancer
construction of organoids from gynecological tumor
organoids construction
cohort of vaginal cancer organoids
organoids derived from vaginal cancer
construction of organoids from gynecological tumor
organoids construction
cohort of gestational trophoblastic tumor organoids
organoids derived from gestational trophoblastic tumor
construction of organoids from gynecological tumor
organoids construction
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
construction of organoids from gynecological tumor
organoids construction
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. The preoperative tumor burden assessment and intraoperative researcher team believe that sampling is feasible;
3. Having relevant requirements for sample library storage;
4. Surgical treatment at Peking Union Medical College Hospital.
2. The research team considers any situations or considerations that may hinder normal pathological assessment.
18 Years
80 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking Union Medical College Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lei Li
professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
K4903 G&O organoids
Identifier Type: -
Identifier Source: org_study_id